HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances
Go back to HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances| (NASDAQ: HCWB) | Delayed: 4.33 -0.25 (5.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.58 | 52 Week High | $ | |||
| Open | $4.49 | 52 Week Low | $ | |||
| Day High | $4.74 | P/E | N/A | |||
| Day Low | $4.22 | EPS | $ | |||
| Volume | 72,546 | |||||
| (NASDAQ: HCWB) | Delayed: 4.33 -0.25 (5.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.58 | 52 Week High | $ | |||
| Open | $4.49 | 52 Week Low | $ | |||
| Day High | $4.74 | P/E | N/A | |||
| Day Low | $4.22 | EPS | $ | |||
| Volume | 72,546 | |||||

